Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.23.5 (
cathepsin D
)
4,130
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cellular interaction with the extracellular milieu plays a significant role in normal biological and pathologic processes. Excessive degradation of basement membrane matrix by proteolytic enzymes is a hallmark of tumor invasion and metastasis, and aspartyl proteinase
cathepsin D
is implicated as a major contributor to this process.
Maspin
, a non-inhibitory serpin, plays an important role in mammary gland development and remodeling. Expression of
Maspin
is decreased in primary tumors and lost in metastatic lesions.
Maspin
is mostly cytoplasmic and is partially secreted; however, the fate and function of secreted
Maspin
has remained mostly unexplored. We hypothesized that secreted
Maspin
is incorporated into the matrix deposited by normal mammary epithelial cells and thus could play a critical role in
cathepsin D
-mediated matrix degradation and remodeling of mammary tissue. In the absence of
Maspin
, as is the case with most cancer cells, matrix degradation proceeds unrestricted, thus facilitating the progression to metastasis. To test this, we employed an in vitro model where gels containing both types I and IV collagen were preconditioned with normal mammary epithelial cells to allow the incorporation of secreted
Maspin
. This conditioned matrix was used to examine
cathepsin D
-mediated collagen degradation by human breast cancer cell lines. Our results indicate that secretion of
Maspin
and its deposition into the extracellular milieu play an important role in matrix degradation. In this capacity,
Maspin
could potentially regulate mammary tissue remodeling occurring under normal and pathologic conditions. In addition, these findings could have a potential effect on future therapeutic intervention strategies for breast cancer.
...
PMID:Elucidating the function of secreted maspin: inhibiting cathepsin D-mediated matrix degradation. 1744 60
In this study we examined the ability of interferon-gamma (IFN-gamma) to regulate mammary epithelial cell growth and gene expression, with particular emphasis on two genes:
Maspin
(a member of serine protease inhibitor superfamily), and the lysosomal aspartyl endopeptidase
cathepsin D
(CatD). The protein products of these genes are critically involved in regulation of multitude of biological functions in different stages of mammary tissue development and remodeling. In addition, the expression of
Maspin
is down-regulated in primary breast cancer and is lost in metastatic disease, while CatD is excessively produced and aberrantly secreted by breast cancer cells. We report that IFN-gamma receptors are expressed in mammary epithelial cells, and receptor engagement by IFN-gamma transduces the IFN-gamma signal via Stat-1 resulting in decreased vacuolar pH. This change in vacuolar pH alters CatD protein processing and secretion concurrent with increased
Maspin
secretion. In addition, IFN-gamma exerts a suppressive effect on cell growth and proliferation, and induces morphological changes in mammary epithelial cells. Our studies also reveal that breast cancer cells, which are devoid of
Maspin
, are refractory to IFN-gamma with respect to changes in vacuolar pH and CatD. However,
Maspin
transfection of breast cancer cells partially sensitizes the cells to IFN-gamma's effect, thus providing new therapeutic implications.
...
PMID:IFN-gamma regulation of vacuolar pH, cathepsin D processing and autophagy in mammary epithelial cells. 1849 1